Clinical Focus

  • Cystic Fibrosis
  • Bronchiectasis
  • Asthma
  • Critical Care
  • Critical Care Medicine

Academic Appointments

Professional Education

  • Board Certification: American Board of Internal Medicine, Critical Care Medicine (2020)
  • Fellowship: Stanford University Pulmonary and Critical Care Fellowship (2020) CA
  • Board Certification: American Academy of Pediatrics, Pediatrics (2018)
  • Board Certification: American Board of Internal Medicine, Internal Medicine (2017)
  • Residency: UCLA Medical Center Internal Medicine (2017) CA
  • Medical Education: Loyola University Stritch School of Medicine (2013) IL
  • Residency, University of California, Los Angeles, Internal Medicine and Pediatrics (2017)
  • M.D., Loyola Stritch School of Medicine (2013)
  • B.S., University of Michigan (2008)

Contact

  • Academic
    University - Academic staff Department: Medicine - Med/Pulmonary and Critical Care Medicine Position: Clinical Assistant Professor
  • Clinical (Primary)  Pulmonary and Critical Care 300 Pasteur Dr A251 MC 5221 Stanford, CA 94305 (650) 498-6288 (fax)

Additional Clinical Info

Additional Info

  • Mail Code: 5236

All Publications

  • Cystic fibrosis telemedicine in the era of COVID-19. JAMIA open Rad, E. J., Mirza, A. A., Chhatwani, L., Purington, N., Mohabir, P. K. 2022; 5 (1): ooac005

    Abstract

    The coronavirus disease 2019 pandemic has resulted in large-scale changes to incorporate telemedicine for the delivery of care. People with cystic fibrosis (CF) have care considerations that pose challenges to telemedicine; they include frequent visits for pulmonary disease progression, medication management, and evaluation by a multidisciplinary team of providers. We share our center's experience with video visits replacing in-person clinic evaluation, using quality improvement strategies to create a replicable workflow. Key considerations include incorporation of the multidisciplinary team into the visit, limitations of remote delivery of care, as well as patient and staff perceptions of this care model. Results revealed that video visits were convenient, efficacious, and comparable to in-person visits, with interest for its continued incorporation into the traditional CF care model.

    View details for DOI 10.1093/jamiaopen/ooac005

    View details for PubMedID 35224457

  • 3D Printing and the Cystic Fibrosis Lung JOURNAL OF CYSTIC FIBROSIS Mirza, A. A., Robinson, T. E., Gifford, K., Guo, H. 2019; 18 (2): 278–79

    View details for DOI 10.1016/j.jcf.2018.09.004

    View details for Web of Science ID 000466454900020

  • Opportunities to Improve Utilization of Palliative Care among Adults with Cystic Fibrosis: A Systematic Review. Journal of pain and symptom management Marmor, M. n., Jonas, A. n., Mirza, A. n., Rad, E. n., Wong, H. n., Aslakson, R. A. 2019

    Abstract

    Individuals with Cystic Fibrosis (CF) frequently survive into adulthood and many have multi-faceted symptoms that impair quality of life.We conducted a systematic review to investigate opportunities to improve utilization of palliative care among adults with CF.We searched PubMed, Embase, Scopus, Web of Science and CINAHL databases from inception until September 27, 2018, and reviewed references manually. Eligible articles were published in English, involved adults age 18 years and older with CF and contained original data regarding patient outcomes related to presence of advanced care planning (ACP), symptom experience, and preferred and/or received end-of-life care.We screened 652 article abstracts and 32 full text articles; 12 studies met inclusion criteria. All studies were published between 2000 and 2018. Pertinent findings include that while 43% to 65% of adults with CF had contemplated completing ACP, the majority only completed ACP during their terminal hospital admission. Patients also reported high prevalence of untreated symptoms, with adequate symptom control reported in 45% among those with dyspnea, 22% among those with pain and 51% among those with anxiety and/or depression. Prevalence of in-hospital death ranged from 62% to 100%, with a third dying in the intensive care unit (ICU). The majority received antibiotics and preventative treatments during their terminal hospitalization. Finally, treatment from a palliative care specialist was associated with a higher prevalence of patient completion of advanced directives, decreased likelihood of in-ICU death and decreased use of mechanical ventilation at end-of-life.Adults with CF often have untreated symptoms and many opportunities exist for palliative care specialists to improve ACP completion and quality of end-of-life care.

    View details for DOI 10.1016/j.jpainsymman.2019.08.017

    View details for PubMedID 31437475

  • 3D Printing and the Cystic Fibrosis Lung. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society Mirza, A. A., Robinson, T. E., Gifford, K., Guo, H. H. 2018

    View details for PubMedID 30361143